|
시장보고서
상품코드
2148371
유전자 전달 플랫폼 시장 : 전달 플랫폼별, 벡터 유형별, 용도별, 최종사용자별, 지역별Gene Delivery Platform Market, By Delivery Platform, By Vector Type, By Application, By End User, By Geography |
||||||
유전자 전달 플랫폼 시장은 2026년에 87억 4,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 245억 2,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 15.9%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 87억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 15.90% | 2033년 시장 규모 예측 : | 245억 2,000만 달러 |
유전자 전달 플랫폼은 분자 의학의 기반이 되는 요소로, 치료, 예방 및 연구를 목적으로 유전 물질을 표적 부위로 전달하는 데 활용되고 있습니다. 이 업계에는 유전자 치료, 유전자 변형, mRNA 전달 및 세포 치료 용도를 위한 AAV, 렌티바이러스, 아데노바이러스 벡터 등의 바이러스형 플랫폼과, 지질 나노입자, 고분자 운반체, 전기천공법 등의 비바이러스형 시스템이 포함됩니다.
전 세계 유전자 전달 플랫폼 시장은 표적 전달 기술의 발전, CRISPR 기반 치료법, 차세대 비바이러스성 시스템, 그리고 유전자 의약품의 임상 적용 확대에 힘입어 성장하고 있습니다. AAV는 여전히 확립된 전달 플랫폼이지만, LNP 및 기타 비바이러스 기술에 대한 관심이 높아짐에 따라 전달 가능한 물질의 범위, 표적화 능력 및 반복 투여 가능성이 확대되고 있습니다.
시장 역학
전 세계 유전자 전달 플랫폼 시장은 유전자 치료 및 세포 치료 파이프라인의 확대, 유전성 질환 발병률 증가, 그리고 AAV, 렌티바이러스 및 비바이러스형 전달 기술의 혁신에 힘입어 성장하고 있습니다. 유전체 편집 치료의 적용 범위 확대와 벡터 공학의 발전으로 전달 용도가 더욱 넓어지고 있으며, 규제 체제의 변화도 개발과 상용화를 지원하고 있습니다.
그러나 유전자 전달 플랫폼 시장의 성장은 높은 개발 및 제조 비용, 벡터의 면역원성, 페이로드 용량, 재현성 있는 대규모 생산 달성의 어려움과 같은 요인들로 인해 제약을 받고 있습니다. 그럼에도 불구하고 정밀 전달 기술의 지속적인 발전에 힘입어 생체내 유전체 편집 전달, 조직 표적형 LNP, 차세대 바이러스 벡터, 그리고 신경질환 및 기타 표적화가 어려운 질환을 위한 전달 시스템에는 큰 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 유전자 전달 플랫폼 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 유전자 전달 플랫폼 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 원활한 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 유전자 전달 플랫폼 시장 : 전달 플랫폼별, 2021-2033년
제5장 세계의 유전자 전달 플랫폼 시장 : 벡터 유형별, 2021-2033년
제6장 세계의 유전자 전달 플랫폼 시장 : 용도별, 2021-2033년
제7장 세계의 유전자 전달 플랫폼 시장 : 최종사용자별, 2021-2033년
제8장 세계의 유전자 전달 플랫폼 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KSA 26.10.19Gene Delivery Platform Market is estimated to be valued at USD 8.74 Bn in 2026 and is expected to reach USD 24.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 8.74 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.90% | 2033 Value Projection: | USD 24.52 Bn |
Gene delivery platforms are a foundational component of molecular medicine and are used for the targeted delivery of genetic material for therapeutic, prophylactic and research purposes. The industry includes viral platforms like AAV, lentiviral and adenoviral vectors, and non-viral systems including lipid nanoparticles, polymeric carriers and electroporation, for gene therapy, gene modification, mRNA delivery and cell therapy applications.
The global gene delivery platform market is driven by advances in targeted delivery, CRISPR-based therapies and next generation non-viral systems, as well as the growing clinical translation of genetic medicines. While AAV remains an established delivery platform, increasing focus on LNPs and other non-viral technologies is expanding the range of payloads, targeting capabilities and potential for repeat administration.
Market Dynamics
The global gene delivery platform market is driven by the growing pipeline of gene and cell therapies, increasing incidence of genetic diseases, and innovations in AAV, lentiviral, and non-viral delivery technologies. Genome-editing therapies' expanding applications and improvements in vector engineering are further broadening delivery applications, while the development and commercialization are also supported by changing regulatory structures.
However, the growth of gene delivery platform market is limited by factors such as high development and manufacturing costs, vector immunogenicity, payload capacity and difficulty in achieving reproducible large-scale production. Nevertheless, significant opportunities exist within in vivo genome-editing delivery, tissue-targeted LNPs, next-generation viral vectors and delivery systems for neurological and other hard-to-target diseases, supported by ongoing advances in precision delivery technologies.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global gene delivery platform market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Catalent, Inc., Oxford Biomedica plc, Takara Bio Inc., Charles River Laboratories International, Inc., and Danaher Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global gene delivery platform market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene delivery platform market
Market Segmentation
- Delivery Platform Insights (Revenue, USD Bn, 2021 - 2033)
- Viral Delivery Platforms
- Non-Viral Delivery Platforms
- Vector Type Insights (Revenue, USD Bn, 2021 - 2033)
- Adeno-Associated Virus (AAV)
- Adenovirus
- Lentivirus
- Other Viral Vectors
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Gene Therapy
- Cell Therapy
- Vaccines
- Research
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutions
- Hospitals and Specialized Treatment Centers
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza Group Ltd.
- Catalent, Inc.
- Oxford Biomedica plc
- Takara Bio Inc.
- Charles River Laboratories International, Inc.
- Danaher Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gene Delivery Platform Market, By Delivery Platform
- Global Gene Delivery Platform Market, By Vector Type
- Global Gene Delivery Platform Market, By Application
- Global Gene Delivery Platform Market, By End User
- Global Gene Delivery Platform Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Delivery Platform Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Gene Delivery Platform Market, By Delivery Platform, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Viral Delivery Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Non-Viral Delivery Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Gene Delivery Platform Market, By Vector Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adeno-Associated Virus (AAV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Adenovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Lentivirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Other Viral Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Gene Delivery Platform Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Gene Delivery Platform Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hospitals and Specialized Treatment Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Gene Delivery Platform Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Catalent, Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Biomedica plc
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories International, Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
